Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “lotilaner”

3 pharma patents match "lotilaner" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "lotilaner" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “lotilaner” · 30,257 patents in full index Clear search

  1. US 11752137

    Ophthalmic compositions for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  2. US 11690826

    Methods for treating demodex blepharitis using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  3. US 11690827

    Methods for treating ocular Demodex using lotilaner formulations

    Tarsus Pharmaceuticals, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.